BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12202469)

  • 1. Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis.
    Cranney A; Tugwell P; Zytaruk N; Robinson V; Weaver B; Shea B; Wells G; Adachi J; Waldegger L; Guyatt G;
    Endocr Rev; 2002 Aug; 23(4):540-51. PubMed ID: 12202469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women.
    Cranney A; Wells G; Willan A; Griffith L; Zytaruk N; Robinson V; Black D; Adachi J; Shea B; Tugwell P; Guyatt G;
    Endocr Rev; 2002 Aug; 23(4):508-16. PubMed ID: 12202465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women.
    Papadimitropoulos E; Wells G; Shea B; Gillespie W; Weaver B; Zytaruk N; Cranney A; Adachi J; Tugwell P; Josse R; Greenwood C; Guyatt G;
    Endocr Rev; 2002 Aug; 23(4):560-9. PubMed ID: 12202471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women.
    Wells G; Tugwell P; Shea B; Guyatt G; Peterson J; Zytaruk N; Robinson V; Henry D; O'Connell D; Cranney A;
    Endocr Rev; 2002 Aug; 23(4):529-39. PubMed ID: 12202468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis.
    Cranney A; Tugwell P; Adachi J; Weaver B; Zytaruk N; Papaioannou A; Robinson V; Shea B; Wells G; Guyatt G;
    Endocr Rev; 2002 Aug; 23(4):517-23. PubMed ID: 12202466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analyses of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis.
    Cranney A; Tugwell P; Zytaruk N; Robinson V; Weaver B; Adachi J; Wells G; Shea B; Guyatt G;
    Endocr Rev; 2002 Aug; 23(4):524-8. PubMed ID: 12202467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis.
    Shea B; Wells G; Cranney A; Zytaruk N; Robinson V; Griffith L; Ortiz Z; Peterson J; Adachi J; Tugwell P; Guyatt G;
    Endocr Rev; 2002 Aug; 23(4):552-9. PubMed ID: 12202470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis.
    Cranney A; Guyatt G; Krolicki N; Welch V; Griffith L; Adachi JD; Shea B; Tugwell P; Wells G;
    Osteoporos Int; 2001; 12(2):140-51. PubMed ID: 11303715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etidronate for treating and preventing postmenopausal osteoporosis.
    Cranney A; Welch V; Adachi JD; Guyatt G; Krolicki N; Griffith L; Shea B; Tugwell P; Wells G
    Cochrane Database Syst Rev; 2001; (4):CD003376. PubMed ID: 11687195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiresorptive treatment of postmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint.
    Marcus R; Wong M; Heath H; Stock JL
    Endocr Rev; 2002 Feb; 23(1):16-37. PubMed ID: 11844743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
    Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
    Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WITHDRAWN: Etidronate for treating and preventing postmenopausal osteoporosis.
    Cranney A; Adachi JD; Griffith L; Guyatt G; Krolicki N; Robinson VA; Shea BJ; Wells G
    Cochrane Database Syst Rev; 2007 Jul; (1):CD003376. PubMed ID: 17636719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoride for the treatment of postmenopausal osteoporotic fractures: a meta-analysis.
    Haguenauer D; Welch V; Shea B; Tugwell P; Adachi JD; Wells G
    Osteoporos Int; 2000; 11(9):727-38. PubMed ID: 11148800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.
    Chesnut CH; Silverman S; Andriano K; Genant H; Gimona A; Harris S; Kiel D; LeBoff M; Maricic M; Miller P; Moniz C; Peacock M; Richardson P; Watts N; Baylink D
    Am J Med; 2000 Sep; 109(4):267-76. PubMed ID: 10996576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium supplementation on bone loss in postmenopausal women.
    Shea B; Wells G; Cranney A; Zytaruk N; Robinson V; Griffith L; Hamel C; Ortiz Z; Peterson J; Adachi J; Tugwell P; Guyatt G; ;
    Cochrane Database Syst Rev; 2003; (4):CD004526. PubMed ID: 14584022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis.
    Cranney A; Welch V; Adachi JD; Homik J; Shea B; Suarez-Almazor ME; Tugwell P; Wells G
    Cochrane Database Syst Rev; 2000; 2000(2):CD001983. PubMed ID: 10796457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials.
    Palmer SC; Strippoli GF; McGregor DO
    Am J Kidney Dis; 2005 Apr; 45(4):638-49. PubMed ID: 15806466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of elcatonin in postmenopausal women with osteoporosis: a systematic review with network meta-analysis of randomized clinical trials.
    Chen WC; Lin EY; Kang YN
    Osteoporos Int; 2019 Sep; 30(9):1723-1732. PubMed ID: 31041475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
    Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D
    J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium supplementation on bone loss in postmenopausal women.
    Shea B; Wells G; Cranney A; Zytaruk N; Robinson V; Griffith L; Hamel C; Ortiz Z; Peterson J; Adachi J; Tugwell P; Guyatt G; ;
    Cochrane Database Syst Rev; 2004; (1):CD004526. PubMed ID: 14974070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.